Skip to main navigation Skip to search Skip to main content

Effect of Cimetidine 800 mg h.s. and 300 mg q.i.d. on the Pharmaceutics of Warfarin in Patients Receiving Maintenance Warfarin Therapy

  • M. J. Sax
  • , W. Randolph
  • , Karl E. Peace
  • , S. Chretian
  • , William O. Frank
  • , D. R. Gray
  • , L. McCree
  • , Alan Braveman
  • , F. Wyle
  • , B. J. Jackson
  • , M. Beg

Research output: Contribution to journal › Article › peer-review

Abstract

This article was published in Clinical Pharmacy.
Original languageAmerican English
JournalClinical Pharmacy
Volume6
StatePublished - 1987

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Biostatistics
  • Public Health

Keywords

  • Cimetidine
  • Effect
  • Maintenance Warfarin therapy
  • Patients
  • Pharmaceutics
  • Warfarin

Fingerprint

Dive into the research topics of 'Effect of Cimetidine 800 mg h.s. and 300 mg q.i.d. on the Pharmaceutics of Warfarin in Patients Receiving Maintenance Warfarin Therapy'. Together they form a unique fingerprint.
View full fingerprint

Cite this